These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

596 related items for PubMed ID: 23321297

  • 1. Impact of the human immunodeficiency virus on early multidrug-resistant tuberculosis treatment outcomes in Botswana.
    Hafkin J, Modongo C, Newcomb C, Lowenthal E, MacGregor RR, Steenhoff AP, Friedman H, Bisson GP.
    Int J Tuberc Lung Dis; 2013 Mar; 17(3):348-53. PubMed ID: 23321297
    [Abstract] [Full Text] [Related]

  • 2. Converging risk factors but no association between HIV infection and multidrug-resistant tuberculosis in Kazakhstan.
    van den Hof S, Tursynbayeva A, Abildaev T, Adenov M, Pak S, Bekembayeva G, Ismailov S.
    Int J Tuberc Lung Dis; 2013 Apr; 17(4):526-31. PubMed ID: 23485387
    [Abstract] [Full Text] [Related]

  • 3. Body mass index predictive of sputum culture conversion among MDR-TB patients in Indonesia.
    Putri FA, Burhan E, Nawas A, Soepandi PZ, Sutoyo DK, Agustin H, Isbaniah F, Dowdy DW.
    Int J Tuberc Lung Dis; 2014 May; 18(5):564-70. PubMed ID: 24903794
    [Abstract] [Full Text] [Related]

  • 4. Increase in anti-tuberculosis drug resistance in Botswana: results from the fourth National Drug Resistance Survey.
    Menzies HJ, Moalosi G, Anisimova V, Gammino V, Sentle C, Bachhuber MA, Bile E, Radisowa K, Kachuwaire O, Basotli J, Maribe T, Makombe R, Shepherd J, Kim B, Samandari T, El-Halabi S, Chirenda J, Cain KP.
    Int J Tuberc Lung Dis; 2014 Sep; 18(9):1026-33. PubMed ID: 25189548
    [Abstract] [Full Text] [Related]

  • 5. Determinants of sputum culture conversion time in multidrug-resistant tuberculosis patients in ALERT comprehensive specialized hospital, Addis Ababa, Ethiopia: A retrospective cohort study.
    Abebe M, Atnafu A, Tilahun M, Sero N, Neway S, Alemu M, Tesfaye G, Mihret A, Bobosha K, Wan C.
    PLoS One; 2024 Sep; 19(5):e0304507. PubMed ID: 38820260
    [Abstract] [Full Text] [Related]

  • 6. Time to treatment and patient outcomes among TB suspects screened by a single point-of-care xpert MTB/RIF at a primary care clinic in Johannesburg, South Africa.
    Hanrahan CF, Selibas K, Deery CB, Dansey H, Clouse K, Bassett J, Scott L, Stevens W, Sanne I, Van Rie A.
    PLoS One; 2013 Sep; 8(6):e65421. PubMed ID: 23762367
    [Abstract] [Full Text] [Related]

  • 7. Clinical outcomes among persons with pulmonary tuberculosis caused by Mycobacterium tuberculosis isolates with phenotypic heterogeneity in results of drug-susceptibility tests.
    Zetola NM, Modongo C, Moonan PK, Ncube R, Matlhagela K, Sepako E, Collman RG, Bisson GP.
    J Infect Dis; 2014 Jun 01; 209(11):1754-63. PubMed ID: 24443546
    [Abstract] [Full Text] [Related]

  • 8. Improved Survival and Cure Rates With Concurrent Treatment for Multidrug-Resistant Tuberculosis-Human Immunodeficiency Virus Coinfection in South Africa.
    Brust JCM, Shah NS, Mlisana K, Moodley P, Allana S, Campbell A, Johnson BA, Master I, Mthiyane T, Lachman S, Larkan LM, Ning Y, Malik A, Smith JP, Gandhi NR.
    Clin Infect Dis; 2018 Apr 03; 66(8):1246-1253. PubMed ID: 29293906
    [Abstract] [Full Text] [Related]

  • 9. Time to sputum smear and culture conversions in multidrug resistant tuberculosis at University of Gondar Hospital, Northwest Ethiopia.
    Shibabaw A, Gelaw B, Wang SH, Tessema B.
    PLoS One; 2018 Apr 03; 13(6):e0198080. PubMed ID: 29944658
    [Abstract] [Full Text] [Related]

  • 10. Integrated, home-based treatment for MDR-TB and HIV in rural South Africa: an alternate model of care.
    Brust JC, Shah NS, Scott M, Chaiyachati K, Lygizos M, van der Merwe TL, Bamber S, Radebe Z, Loveday M, Moll AP, Margot B, Lalloo UG, Friedland GH, Gandhi NR.
    Int J Tuberc Lung Dis; 2012 Aug 03; 16(8):998-1004. PubMed ID: 22668560
    [Abstract] [Full Text] [Related]

  • 11. Community-based treatment of drug-resistant tuberculosis in Khayelitsha, South Africa.
    Cox H, Hughes J, Daniels J, Azevedo V, McDermid C, Poolman M, Boulle A, Goemaere E, van Cutsem G.
    Int J Tuberc Lung Dis; 2014 Apr 03; 18(4):441-8. PubMed ID: 24670700
    [Abstract] [Full Text] [Related]

  • 12. Treatment and outcomes in children with multidrug-resistant tuberculosis: A systematic review and individual patient data meta-analysis.
    Harausz EP, Garcia-Prats AJ, Law S, Schaaf HS, Kredo T, Seddon JA, Menzies D, Turkova A, Achar J, Amanullah F, Barry P, Becerra M, Chan ED, Chan PC, Ioana Chiotan D, Crossa A, Drobac PC, Fairlie L, Falzon D, Flood J, Gegia M, Hicks RM, Isaakidis P, Kadri SM, Kampmann B, Madhi SA, Marais E, Mariandyshev A, Méndez-Echevarría A, Moore BK, Nargiza P, Ozere I, Padayatchi N, Ur-Rehman S, Rybak N, Santiago-Garcia B, Shah NS, Sharma S, Shim TS, Skrahina A, Soriano-Arandes A, van den Boom M, van der Werf MJ, van der Werf TS, Williams B, Yablokova E, Yim JJ, Furin J, Hesseling AC, Collaborative Group for Meta-Analysis of Paediatric Individual Patient Data in MDR-TB.
    PLoS Med; 2018 Jul 03; 15(7):e1002591. PubMed ID: 29995958
    [Abstract] [Full Text] [Related]

  • 13. Pilot study on multidrug resistant tuberculosis in Nigeria.
    Lawson L, Habib AG, Okobi MI, Idiong D, Olajide I, Emenyonu N, Onuoha N, Cuevas LE, Ogiri SO.
    Ann Afr Med; 2010 Jul 03; 9(3):184-7. PubMed ID: 20710112
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. HIV-positive patients treated for multidrug-resistant tuberculosis: clinical outcomes in the HAART era.
    Palacios E, Franke M, Muñoz M, Hurtado R, Dallman R, Chalco K, Guerra D, Mestanza L, Llaro K, Bonilla C, Sebastian J, Bayona J, Lygizos M, Anger H, Shin S.
    Int J Tuberc Lung Dis; 2012 Jul 03; 16(3):348-54. PubMed ID: 22640448
    [Abstract] [Full Text] [Related]

  • 16. Linezolid-containing regimens for the treatment of drug-resistant tuberculosis in South African children.
    Rose PC, Hallbauer UM, Seddon JA, Hesseling AC, Schaaf HS.
    Int J Tuberc Lung Dis; 2012 Dec 03; 16(12):1588-93. PubMed ID: 23032215
    [Abstract] [Full Text] [Related]

  • 17. Time to sputum culture conversion in multidrug-resistant tuberculosis: predictors and relationship to treatment outcome.
    Holtz TH, Sternberg M, Kammerer S, Laserson KF, Riekstina V, Zarovska E, Skripconoka V, Wells CD, Leimane V.
    Ann Intern Med; 2006 May 02; 144(9):650-9. PubMed ID: 16670134
    [Abstract] [Full Text] [Related]

  • 18. Intensive-phase treatment outcomes among hospitalized multidrug-resistant tuberculosis patients: results from a nationwide cohort in Nigeria.
    Oladimeji O, Isaakidis P, Obasanya OJ, Eltayeb O, Khogali M, Van den Bergh R, Kumar AM, Hinderaker SG, Abdurrahman ST, Lawson L, Cuevas LE.
    PLoS One; 2014 May 02; 9(4):e94393. PubMed ID: 24722139
    [Abstract] [Full Text] [Related]

  • 19. Tuberculosis Treatment Outcome and Drug Resistance in Lambaréné, Gabon: A Prospective Cohort Study.
    Bélard S, Remppis J, Bootsma S, Janssen S, Kombila DU, Beyeme JO, Rossatanga EG, Kokou C, Osbak KK, Obiang Mba RM, Kaba HM, Traoré AN, Ehrhardt J, Bache EB, Flamen A, Rüsch-Gerdes S, Frank M, Adegnika AA, Lell B, Niemann S, Kremsner PG, Loembé MM, Alabi AS, Grobusch MP.
    Am J Trop Med Hyg; 2016 Aug 03; 95(2):472-80. PubMed ID: 27352879
    [Abstract] [Full Text] [Related]

  • 20. Predictors and mortality associated with treatment default in pulmonary tuberculosis.
    Kliiman K, Altraja A.
    Int J Tuberc Lung Dis; 2010 Apr 03; 14(4):454-63. PubMed ID: 20202304
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.